FDA Drugs recall ·
Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL… recall
- Recall number
- D-0244-2026
- Date
- (initiated December 19, 2025)
- Company / brand
- Novo Nordisk Inc.
800 Scudders Mill Rd, Plainsboro, NJ, United States - Category
- Drugs › Class II
- Classification
- Class II
- Status
- Ongoing
- Units affected
- N/A
- Initiated by
- Voluntary: Firm initiated
Read the official FDA notice ↗
Product
Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4505-14
Why was it recalled?
Presence of Particulate Matter: Hair was found in a prefilled syringe
What should you do?
FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.
Product codes & lot numbers
Lot #: RZFHD52, RZFHW93; Exp Date 10/31/2026
Distribution
Nationwide within the United States.
What does Class II mean?
Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.
Source: FDA (drugs), recall D-0244-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.